Clinical Trials Update: Dec. 20, 2005
Eczema (Atopic Dermatitis - Pediatric) Hyperparathyroidism Hepatitis C; Chronic
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Eczema (Atopic Dermatitis - Pediatric)
The Pediatric and Adolescent Dermatology office at Children's Hospital in San Diego is conducting a research study to help treat pediatric eczema.
This new study is assessing a skin cream compared to a placebo (no active ingredient) to help treat the condition. The study is enrolling children 6 months to 12 years of age with mild-to-moderate eczema.
The research site is in San Diego.
People with secondary hyperparathyroidism associated with end stage renal disease are asked to participate in a research study being conducted by North Shore University Hospital in Long Island, N.Y.
You may be eligible to participate in this study if you are at least 18 years of age and have been undergoing dialysis for one-to-6 months.
The research site is in Great Neck, N.Y.
Hepatitis C; Chronic
The purpose of this study is to see how safe it is to take NM283 and pegylated interferon alfa together and to measure how well this drug combination works to help get rid of hepatitis C.
Participation may last for up to one and a half years and includes about 20 clinic visits. You may be eligible to participate if you are between 18 and 65 years old, have been diagnosed with hepatitis C and have not yet received treatment.
The research site is in New York City.
Copyright 2005 CenterWatch. All rights reserved.